ABCELLERA BIOLOGICS Strategic Asset Allocation Index
ABCELLERA BIOLOGICS strategic asset allocation index. ABCELLERA BIOLOGICS (8QQ) has a Strategic Asset Allocation Index of 7.3% as of June 2026. Strategic assets (PP&E of €- plus long-term investments of €65.23 Million) total €65.23 Million, measured against net assets of €896.02 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See ABCELLERA BIOLOGICS balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of ABCELLERA BIOLOGICS (2021–2025)
Strategic asset allocation index of ABCELLERA BIOLOGICS from 2021 to 2025. This chart shows how ABCELLERA BIOLOGICS's Strategic Asset Allocation Index has evolved across 5 annual periods from 2021 to 2025. As of June 2026, the index stands at 7.3%, representing strategic assets of €65.23 Million against net assets of €896.02 Million EUR. Check 8QQ tangible net worth ratio to evaluate the tangible quality of the company's equity base.
ABCELLERA BIOLOGICS Strategic Asset Allocation Index by Year (2021–2025)
ABCELLERA BIOLOGICS strategic asset allocation index by year from 2021 to 2025. The table below presents the year-by-year Strategic Asset Allocation Index for ABCELLERA BIOLOGICS from 2021 to 2025, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of ABCELLERA BIOLOGICS.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 6.5% | €62.58 Million | €- | €62.58 Million | €966.90 Million | ▼ -1.3 pp |
| 2024 | 7.8% | €82.30 Million | €- | €82.30 Million | €1.06 Billion | ▲ +2.1 pp |
| 2023 | 5.7% | €65.94 Million | €- | €65.94 Million | €1.15 Billion | ▼ -0.2 pp |
| 2022 | 5.9% | €72.52 Million | €- | €72.52 Million | €1.23 Billion | ▲ +1.0 pp |
| 2021 | 4.9% | €50.31 Million | €- | €50.31 Million | €1.03 Billion | — |